St. Jude Medical, Inc. STJ, a global medical device company, today
announced the acquisition of Endosense SA, a Switzerland-based company that
has pioneered contact-force measurement in catheter ablation. The acquisition
adds to the company's leading electrophysiology portfolio and provides a
robust platform for future product development.
St. Jude Medical has made an initial payment of approximately 159 million
Swiss francs ($170 million USD) and acquired 100 percent of the outstanding
equity of Endosense. The terms of the transaction also provide for an
additional cash payment of up to 150 million Swiss francs ($161 million USD),
which is contingent upon both the achievement and timing of a regulatory
milestone. The company funded the initial payment using available cash from
outside of the U.S. and expects to make any future payments using these same
cash balances. Except for acquisition-related expenses, this acquisition does
not impact St. Jude Medical's outlook for 2013 consolidated earnings per
share.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in